Last 12 months
Inside the activity.
0 purchase rows · 31 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 0 | 11 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 15 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 3 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 21, 2022 Filed Apr 21, 2022 20:23 UTC |
Francisco Ma. FatimaCEO - Baby, Fem & Family Care
|
Exercise / conversionCommon Stock | 16,000 | $85.13 | $1,362,080.00 |
DisclosureSEC source: 0001127602-22-012309 · form4.xml · nonDerivative · entry 2 Francisco Ma. Fatima · CIK 0001747222 · CEO - Baby, Fem & Family Care 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,020.1413 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 21, 2022 Filed Apr 21, 2022 20:23 UTC |
Francisco Ma. FatimaCEO - Baby, Fem & Family Care
|
SaleCommon Stock | 2,000 | $164.64 | $329,270.00 |
DisclosureSEC source: 0001127602-22-012309 · form4.xml · nonDerivative · entry 1 Francisco Ma. Fatima · CIK 0001747222 · CEO - Baby, Fem & Family Care 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,020.1413 F1 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) settled in common stock. Read SEC document |
| April 21, 2022 Filed Apr 22, 2022 20:22 UTC |
Keith R. AlexandraCEO - Beauty
|
SaleCommon Stock | 1,335 | $163.50 | $218,272.50 |
DisclosureSEC source: 0001127602-22-012417 · form4.xml · nonDerivative · entry 2 Keith R. Alexandra · CIK 0001710268 · CEO - Beauty 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 7,571.1398 Read SEC document |
| April 21, 2022 Filed Apr 22, 2022 20:22 UTC |
Keith R. AlexandraCEO - Beauty
|
SaleCommon Stock | 6,854 | $163.50 | $1,120,629.00 |
DisclosureSEC source: 0001127602-22-012417 · form4.xml · nonDerivative · entry 1 Keith R. Alexandra · CIK 0001710268 · CEO - Beauty 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,791.548 Read SEC document |
| April 21, 2022 Filed Apr 22, 2022 20:24 UTC |
Taylor David SDirector · Executive Chairman
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 60,000 | $0.00 Strike: $88.06 | $0.00 |
DisclosureSEC source: 0001127602-22-012419 · form4.xml · derivative · entry 4 Taylor David S · CIK 0001505989 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,874 Underlying: Common Stock · 60,000 shares Expires 2026-09-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 21, 2022 Filed Apr 22, 2022 20:24 UTC |
Taylor David SDirector · Executive Chairman
|
SaleCommon Stock | 60,000 | $164.52 | $9,871,458.00 |
DisclosureSEC source: 0001127602-22-012419 · form4.xml · nonDerivative · entry 2 Taylor David S · CIK 0001505989 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 253,932.7931 F1 · price: Weighted average price of the shares sold. The price range was $164.32 to $164.67. Full information regarding the number of shares sold at each separate price available upon request. Read SEC document |
| April 21, 2022 Filed Apr 22, 2022 20:24 UTC |
Taylor David SDirector · Executive Chairman
|
Exercise / conversionCommon Stock | 60,000 | $88.06 | $5,283,600.00 |
DisclosureSEC source: 0001127602-22-012419 · form4.xml · nonDerivative · entry 1 Taylor David S · CIK 0001505989 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 313,932.7931 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 08, 2022 Filed Mar 9, 2022 20:18 UTC |
Allen Bertrand MarcDirector
|
GrantCommon Stock | 171 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-008759 · form4.xml · nonDerivative · entry 1 Allen Bertrand Marc · CIK 0001632131 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,353.613 F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2019 Stock and Incentive Compensation Plan. F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) settled in common stock. Read SEC document |
| March 08, 2022 Filed Mar 9, 2022 20:20 UTC |
Braly Angela FDirector
|
GrantCommon Stock | 205 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-008760 · form4.xml · nonDerivative · entry 1 Braly Angela F · CIK 0001321458 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,834.1471 F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2019 Stock and Incentive Compensation Plan. F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) and shares acquired through the issuer's dividend reinvestment plan. Read SEC document |
| March 08, 2022 Filed Mar 9, 2022 20:21 UTC |
JIMENEZ JOSEPHDirector
|
GrantCommon Stock | 239 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-008761 · form4.xml · nonDerivative · entry 1 JIMENEZ JOSEPH · CIK 0001199095 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,167.3631 F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2019 Stock and Incentive Compensation Plan. F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) settled in common stock. Read SEC document |
| March 08, 2022 Filed Mar 9, 2022 20:23 UTC |
Kempczinski Christopher JDirector
|
GrantCommon Stock | 171 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-008762 · form4.xml · nonDerivative · entry 1 Kempczinski Christopher J · CIK 0001598115 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,595.136 F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2019 Stock and Incentive Compensation Plan. F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) settled in common stock. Read SEC document |
| March 08, 2022 Filed Mar 9, 2022 20:24 UTC |
LUNDGREN TERRY JDirector
|
GrantCommon Stock | 213 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-008763 · form4.xml · nonDerivative · entry 1 LUNDGREN TERRY J · CIK 0001184471 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,361.8422 F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2019 Stock and Incentive Compensation Plan. F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) and shares acquired through the issuer's dividend reinvestment plan. Read SEC document |
| March 08, 2022 Filed Mar 9, 2022 20:25 UTC |
McCarthy Christine MDirector
|
GrantCommon Stock | 171 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-008764 · form4.xml · nonDerivative · entry 1 McCarthy Christine M · CIK 0001332169 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,640.1813 F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2019 Stock & Incentive Compensation Plan. F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) settled in common stock. Read SEC document |
| March 08, 2022 Filed Mar 9, 2022 20:26 UTC |
WOERTZ PATRICIA ADirector
|
GrantCommon Stock | 222 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-008765 · form4.xml · nonDerivative · entry 1 WOERTZ PATRICIA A · CIK 0001194945 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,187.6231 F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2019 Stock and Incentive Compensation Plan. F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) settled in common stock. Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 14:47 UTC |
Keith R. AlexandraCEO - Beauty
|
SaleCommon Stock | 1,054 | $153.51 | $161,800.59 |
DisclosureSEC source: 0001127602-22-007872 · form4.xml · nonDerivative · entry 3 Keith R. Alexandra · CIK 0001710268 · CEO - Beauty 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 8,906.1398 F3 · shares: Shares sold to cover tax obligation upon settlement of Restricted Stock Unit award. Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 14:47 UTC |
Keith R. AlexandraCEO - Beauty
|
SaleCommon Stock | 5,777 | $153.51 | $886,833.62 |
DisclosureSEC source: 0001127602-22-007872 · form4.xml · nonDerivative · entry 2 Keith R. Alexandra · CIK 0001710268 · CEO - Beauty 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,645.548 F3 · shares: Shares sold to cover tax obligation upon settlement of Restricted Stock Unit award. F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) settled in common stock. Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 14:47 UTC |
Keith R. AlexandraCEO - Beauty
|
GrantCommon Stock | 3,262 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-007872 · form4.xml · nonDerivative · entry 1 Keith R. Alexandra · CIK 0001710268 · CEO - Beauty 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 9,960.1398 F1 · price: Stock award pursuant to issuer's 2019 Stock and Incentive Compensation Plan. F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) settled in common stock. Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 14:50 UTC |
Schulten AndreChief Financial Officer
|
SaleCommon Stock | 1,335 | $153.51 | $204,937.85 |
DisclosureSEC source: 0001127602-22-007873 · form4.xml · nonDerivative · entry 1 Schulten Andre · CIK 0001844763 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,221.127 F1 · shares: Shares sold to cover tax obligations upon settlement of Restricted Stock Unit Award. F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) settled in common stock. Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 14:54 UTC |
TASTAD CAROLYN MCEO - Health Care
|
SaleCommon Stock | 3,730 | $153.51 | $572,596.78 |
DisclosureSEC source: 0001127602-22-007874 · form4.xml · nonDerivative · entry 1 TASTAD CAROLYN M · CIK 0001597938 · CEO - Health Care 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,156.0655 F1 · shares: Shares sold to cover tax obligations upon settlement of Restricted Stock Unit award. F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) settled in common stock. Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 14:57 UTC |
Taylor David SDirector · Executive Chairman
|
SaleCommon Stock | 12,953 | $153.51 | $1,988,430.57 |
DisclosureSEC source: 0001127602-22-007875 · form4.xml · nonDerivative · entry 1 Taylor David S · CIK 0001505989 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 253,932.7931 F1 · shares: Shares sold to cover tax obligations upon settlement of Restricted Stock Unit award. F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) settled in common stock. Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 15:04 UTC |
Majoras Deborah PChief Legal Officer & Secy
|
SaleCommon Stock | 1,927 | $153.51 | $295,815.31 |
DisclosureSEC source: 0001127602-22-007876 · form4.xml · nonDerivative · entry 1 Majoras Deborah P · CIK 0001483177 · Chief Legal Officer & Secy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,215.6778 F1 · shares: Shares sold to cover tax obligations upon settlement of Restricted Stock Unit award. F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) settled in common stock. Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 15:07 UTC |
Janzaruk Matthew W.SVP - Chief Accounting Officer
|
SaleCommon Stock | 155 | $153.51 | $23,793.97 |
DisclosureSEC source: 0001127602-22-007877 · form4.xml · nonDerivative · entry 1 Janzaruk Matthew W. · CIK 0001910008 · SVP - Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,553.7485 F1 · shares: Shares sold to cover tax obligations upon settlement of Restricted Stock Unit Award. Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 19:54 UTC |
Moeller Jon RDirector · President and CEO
|
SaleCommon Stock | 315 | $153.51 | $48,355.90 |
DisclosureSEC source: 0001127602-22-007943 · form4.xml · nonDerivative · entry 2 Moeller Jon R · CIK 0001450613 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 34,506.6284 F1 · shares: Shares sold to cover tax obligations upon settlement of Restricted Stock Unit award. F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) settled in common stock. Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 19:54 UTC |
Moeller Jon RDirector · President and CEO
|
SaleCommon Stock | 3,231 | $153.51 | $495,994.69 |
DisclosureSEC source: 0001127602-22-007943 · form4.xml · nonDerivative · entry 1 Moeller Jon R · CIK 0001450613 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 164,564.3861 F1 · shares: Shares sold to cover tax obligations upon settlement of Restricted Stock Unit award. F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) settled in common stock. Read SEC document |
| February 15, 2022 Filed Mar 3, 2022 14:47 UTC |
Keith R. AlexandraCEO - Beauty
|
GrantRestricted Stock Units · Derivative | 29.7331 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-007872 · form4.xml · derivative · entry 6 Keith R. Alexandra · CIK 0001710268 · CEO - Beauty 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 414.0853 Underlying: Common Stock · 29.7331 shares Expires not disclosed F5 · derivative.exercise_price: Dividend equivalents in the form of Restricted Stock Units (RSUs) previously awarded pursuant to issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock. F6 · derivative.exercise_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. F6 · derivative.expiration_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. Read SEC document |
| February 15, 2022 Filed Mar 3, 2022 14:50 UTC |
Schulten AndreChief Financial Officer
|
GrantRestricted Stock Units · Derivative | 2.8058 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-007873 · form4.xml · derivative · entry 3 Schulten Andre · CIK 0001844763 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6.0282 Underlying: Common Stock · 2.8058 shares Expires not disclosed F4 · derivative.exercise_price: Dividend equivalents in the form of Restricted Stock Units (RSUs) previously awarded pursuant to issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock. F5 · derivative.exercise_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. F5 · derivative.expiration_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. Read SEC document |
| February 15, 2022 Filed Mar 3, 2022 14:54 UTC |
TASTAD CAROLYN MCEO - Health Care
|
GrantRestricted Stock Units · Derivative | 38.8111 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-007874 · form4.xml · derivative · entry 5 TASTAD CAROLYN M · CIK 0001597938 · CEO - Health Care 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 658.9166 Underlying: Common Stock · 38.8111 shares Expires not disclosed F4 · derivative.exercise_price: Dividend equivalents in the form of Restricted Stock Units (RSUs) previously awarded pursuant to issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock. F5 · derivative.exercise_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. F5 · derivative.expiration_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. Read SEC document |
| February 15, 2022 Filed Mar 3, 2022 14:57 UTC |
Taylor David SDirector · Executive Chairman
|
GrantRestricted Stock Units · Derivative | 26.8565 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-007875 · form4.xml · derivative · entry 3 Taylor David S · CIK 0001505989 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 116.6849 Underlying: Common Stock · 26.8565 shares Expires not disclosed F3 · derivative.exercise_price: Dividend equivalents in the form of Restricted Stock Units (RSUs) previously awarded pursuant to issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock. F4 · derivative.exercise_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. F4 · derivative.expiration_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. Read SEC document |
| February 15, 2022 Filed Mar 3, 2022 15:04 UTC |
Majoras Deborah PChief Legal Officer & Secy
|
GrantRestricted Stock Units · Derivative | 73.0146 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-007876 · form4.xml · derivative · entry 3 Majoras Deborah P · CIK 0001483177 · Chief Legal Officer & Secy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,094.4201 Underlying: Common Stock · 73.0146 shares Expires not disclosed F4 · derivative.exercise_price: Dividend equivalents in the form of Restricted Stock Units (RSUs) previously awarded pursuant to issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock. F5 · derivative.exercise_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. F5 · derivative.expiration_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. Read SEC document |
| February 15, 2022 Filed Mar 3, 2022 19:54 UTC |
Moeller Jon RDirector · President and CEO
|
GrantRestricted Stock Units · Derivative | 129.096 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-007943 · form4.xml · derivative · entry 4 Moeller Jon R · CIK 0001450613 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,191.1615 Underlying: Common Stock · 129.096 shares Expires not disclosed F3 · derivative.exercise_price: Dividend equivalents in the form of Restricted Stock Units (RSUs) previously awarded pursuant to issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock. F4 · derivative.exercise_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. F4 · derivative.expiration_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. Read SEC document |
| February 15, 2022 Filed Apr 21, 2022 20:23 UTC |
Francisco Ma. FatimaCEO - Baby, Fem & Family Care
|
GrantRestricted Stock Units · Derivative | 23.1204 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-012309 · form4.xml · derivative · entry 6 Francisco Ma. Fatima · CIK 0001747222 · CEO - Baby, Fem & Family Care 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 251.1883 Underlying: Common Stock · 23.1204 shares Expires not disclosed F4 · derivative.exercise_price: Dividend equivalents in the form of Restricted Stock Units (RSUs) previously awarded pursuant to issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock. F5 · derivative.exercise_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. F5 · derivative.expiration_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. Read SEC document |
| February 15, 2022 Filed Jul 8, 2022 15:06 UTC |
Raman Sundar G.CEO-Fabric & Home Care
|
GrantRestricted Stock Units · Derivative | 6.0186 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-019081 · form4.xml · derivative · entry 3 Raman Sundar G. · CIK 0001882672 · CEO-Fabric & Home Care 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11.9564 Underlying: Common Stock · 6.0186 shares Expires not disclosed F4 · derivative.exercise_price: Dividend equivalents in the form of Restricted Stock Units (RSUs) previously awarded pursuant to issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock. F5 · derivative.exercise_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. F5 · derivative.expiration_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. Read SEC document |
| February 15, 2022 Filed Aug 4, 2022 20:07 UTC |
Aguilar Moses Victor JavierChf Rsch, Dev & Innov Officer
|
GrantRestricted Stock Units · Derivative | 1.869 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-020473 · form4.xml · derivative · entry 4 Aguilar Moses Victor Javier · CIK 0001825382 · Chf Rsch, Dev & Innov Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3.9621 Underlying: Common Stock · 1.869 shares Expires not disclosed F3 · derivative.exercise_price: Dividend equivalents in the form of Restricted Stock Units (RSUs) previously awarded pursuant to issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock. F4 · derivative.exercise_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. F4 · derivative.expiration_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. Read SEC document |
| February 15, 2022 Filed Aug 4, 2022 20:09 UTC |
Coombe Gary ACEO - Grooming
|
GrantRestricted Stock Units · Derivative | 27.5133 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-020474 · form4.xml · derivative · entry 4 Coombe Gary A · CIK 0001623622 · CEO - Grooming 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 479.3164 Underlying: Common Stock · 27.5133 shares Expires not disclosed F1 · derivative.exercise_price: Dividend equivalents in the form of Restricted Stock Units (RSUs) previously awarded pursuant to issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock. F2 · derivative.exercise_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. F2 · derivative.expiration_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. Read SEC document |
| February 15, 2022 Filed Aug 5, 2022 16:46 UTC |
Jejurikar ShaileshChief Operating Officer
|
GrantRestricted Stock Units · Derivative | 16.4824 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-020530 · form4.xml · derivative · entry 6 Jejurikar Shailesh · CIK 0001746310 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 199.0649 Underlying: Common Stock · 16.4824 shares Expires not disclosed F3 · derivative.exercise_price: Dividend equivalents in the form of Restricted Stock Units (RSUs) previously awarded pursuant to issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock. F4 · derivative.exercise_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. F4 · derivative.expiration_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. Read SEC document |
| February 15, 2022 Filed Aug 5, 2022 17:10 UTC |
Grabowski Mary TheresaChief Human Resources Officer
|
GrantRestricted Stock Units · Derivative | 8.8534 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-020532 · form4.xml · derivative · entry 4 Grabowski Mary Theresa · CIK 0001747030 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55.8899 Underlying: Common Stock · 8.8534 shares Expires not disclosed F3 · derivative.exercise_price: Dividend equivalents in the form of Restricted Stock Units (RSUs) previously awarded pursuant to issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock. F4 · derivative.exercise_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. F4 · derivative.expiration_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. Read SEC document |
| February 15, 2022 Filed Aug 5, 2022 17:43 UTC |
Pritchard Marc S.Chief Brand Officer
|
GrantRestricted Stock Units · Derivative | 157.871 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-020533 · form4.xml · derivative · entry 7 Pritchard Marc S. · CIK 0001440364 · Chief Brand Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,985.3443 Underlying: Common Stock · 157.871 shares Expires not disclosed F3 · derivative.exercise_price: Dividend equivalents in the form of Restricted Stock Units (RSUs) previously awarded pursuant to issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock. F4 · derivative.exercise_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. F4 · derivative.expiration_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. Read SEC document |
| February 03, 2022 Filed Aug 5, 2022 16:46 UTC |
Jejurikar ShaileshChief Operating Officer
|
GiftCommon Stock | 311 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-020530 · form4.xml · nonDerivative · entry 1 Jejurikar Shailesh · CIK 0001746310 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Indirect · Shailesh Jejurikar Trust Disclosed balance after: 721 Read SEC document |
| February 02, 2022 Filed Feb 3, 2022 22:54 UTC |
Taylor David SDirector · Executive Chairman
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 30,095 | $0.00 Strike: $80.29 | $0.00 |
DisclosureSEC source: 0001127602-22-003242 · form4.xml · derivative · entry 4 Taylor David S · CIK 0001505989 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 30,095 shares Expires 2026-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 02, 2022 Filed Feb 3, 2022 22:54 UTC |
Taylor David SDirector · Executive Chairman
|
SaleCommon Stock | 30,095 | $162.00 | $4,875,390.00 |
DisclosureSEC source: 0001127602-22-003242 · form4.xml · nonDerivative · entry 2 Taylor David S · CIK 0001505989 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 266,342.9867 Read SEC document |
| February 02, 2022 Filed Feb 3, 2022 22:54 UTC |
Taylor David SDirector · Executive Chairman
|
Exercise / conversionCommon Stock | 30,095 | $80.29 | $2,416,327.55 |
DisclosureSEC source: 0001127602-22-003242 · form4.xml · nonDerivative · entry 1 Taylor David S · CIK 0001505989 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 296,437.9867 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 31, 2022 Filed Feb 1, 2022 23:51 UTC |
Moeller Jon RDirector · President and CEO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 20,857 | $0.00 Strike: $91.07 | $0.00 |
DisclosureSEC source: 0001127602-22-002830 · form4.xml · derivative · entry 10 Moeller Jon R · CIK 0001450613 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 0 Underlying: Common Stock · 20,857 shares Expires 2027-02-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 31, 2022 Filed Feb 1, 2022 23:51 UTC |
Moeller Jon RDirector · President and CEO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 25,607 | $0.00 Strike: $80.29 | $0.00 |
DisclosureSEC source: 0001127602-22-002830 · form4.xml · derivative · entry 9 Moeller Jon R · CIK 0001450613 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 0 Underlying: Common Stock · 25,607 shares Expires 2026-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 31, 2022 Filed Feb 1, 2022 23:51 UTC |
Moeller Jon RDirector · President and CEO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 59,156 | $0.00 Strike: $91.07 | $0.00 |
DisclosureSEC source: 0001127602-22-002830 · form4.xml · derivative · entry 8 Moeller Jon R · CIK 0001450613 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 59,156 shares Expires 2027-02-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 31, 2022 Filed Feb 1, 2022 23:51 UTC |
Moeller Jon RDirector · President and CEO
|
SaleCommon Stock | 20,857 | $160.01 | $3,337,247.23 |
DisclosureSEC source: 0001127602-22-002830 · form4.xml · nonDerivative · entry 6 Moeller Jon R · CIK 0001450613 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 34,813.3207 F2 · price: Weighted average price of the shares sold. The price range was $160.00 to $160.05. Full information regarding the number of shares sold at each separate price available upon request. Read SEC document |
| January 31, 2022 Filed Feb 1, 2022 23:51 UTC |
Moeller Jon RDirector · President and CEO
|
Exercise / conversionCommon Stock | 20,857 | $91.07 | $1,899,446.99 |
DisclosureSEC source: 0001127602-22-002830 · form4.xml · nonDerivative · entry 5 Moeller Jon R · CIK 0001450613 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 55,670.3207 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 31, 2022 Filed Feb 1, 2022 23:51 UTC |
Moeller Jon RDirector · President and CEO
|
SaleCommon Stock | 25,607 | $160.01 | $4,097,276.20 |
DisclosureSEC source: 0001127602-22-002830 · form4.xml · nonDerivative · entry 4 Moeller Jon R · CIK 0001450613 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 34,813.3207 F2 · price: Weighted average price of the shares sold. The price range was $160.00 to $160.05. Full information regarding the number of shares sold at each separate price available upon request. Read SEC document |
| January 31, 2022 Filed Feb 1, 2022 23:51 UTC |
Moeller Jon RDirector · President and CEO
|
Exercise / conversionCommon Stock | 25,607 | $80.29 | $2,055,986.03 |
DisclosureSEC source: 0001127602-22-002830 · form4.xml · nonDerivative · entry 3 Moeller Jon R · CIK 0001450613 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 60,420.3207 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 31, 2022 Filed Feb 1, 2022 23:51 UTC |
Moeller Jon RDirector · President and CEO
|
SaleCommon Stock | 59,156 | $160.01 | $9,465,326.77 |
DisclosureSEC source: 0001127602-22-002830 · form4.xml · nonDerivative · entry 2 Moeller Jon R · CIK 0001450613 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 167,571.6501 F1 · price: Weighted average price of the shares sold. The price range was $160.00 to $160.06. Full information regarding the number of shares sold at each separate price available upon request. Read SEC document |
| January 31, 2022 Filed Feb 1, 2022 23:51 UTC |
Moeller Jon RDirector · President and CEO
|
Exercise / conversionCommon Stock | 59,156 | $91.07 | $5,387,336.92 |
DisclosureSEC source: 0001127602-22-002830 · form4.xml · nonDerivative · entry 1 Moeller Jon R · CIK 0001450613 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 226,727.6501 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.